Sbi-Securities-Co

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-02
Total Holdings
4,132
Total Value
2997716131
Accession Number
0001851815-25-000004
Form Type
13F-HR
Manager Name
Sbi-Securities-Co
Data Enrichment
81% identified
3,363 identified769 unidentified

Holdings

4,132 positions • $3.0B total value
Manager:
Search and click to pin securities to the top
Page 176 of 207
00437E102
Shares:12
Value:$84
% of Portfolio:0.0% ($84/$3.0B)
LEMAITRE VASCULAR INC
Shares:1
Value:$84
% of Portfolio:0.0% ($84/$3.0B)
Preferred Bank
Shares:1
Value:$84
% of Portfolio:0.0% ($84/$3.0B)
Forward Industries, Inc.
Shares:20
Value:$83
% of Portfolio:0.0% ($83/$3.0B)
M82618113
Shares:285
Value:$83
% of Portfolio:0.0% ($83/$3.0B)
MARCUS CORP
Shares:5
Value:$83
% of Portfolio:0.0% ($83/$3.0B)
Aprea Therapeutics, Inc.
Shares:40
Value:$82
% of Portfolio:0.0% ($82/$3.0B)
MEXCO ENERGY CORP
Shares:10
Value:$82
% of Portfolio:0.0% ($82/$3.0B)
MAXCYTE, INC.
Shares:30
Value:$82
% of Portfolio:0.0% ($82/$3.0B)
BGSF, INC.
Shares:22
Value:$81
% of Portfolio:0.0% ($81/$3.0B)
Janux Therapeutics, Inc.
Shares:3
Value:$81
% of Portfolio:0.0% ($81/$3.0B)
CAMDEN NATIONAL CORP
Shares:2
Value:$81
% of Portfolio:0.0% ($81/$3.0B)
Spyre Therapeutics, Inc.
Shares:5
Value:$81
% of Portfolio:0.0% ($81/$3.0B)
Aveanna Healthcare Holdings, Inc.
Shares:15
Value:$81
% of Portfolio:0.0% ($81/$3.0B)
Akero Therapeutics, Inc.
Shares:2
Value:$81
% of Portfolio:0.0% ($81/$3.0B)
Cytek Biosciences, Inc.
Shares:20
Value:$80
% of Portfolio:0.0% ($80/$3.0B)
Bolt Biotherapeutics, Inc.
Shares:200
Value:$80
% of Portfolio:0.0% ($80/$3.0B)
71902K303
Shares:110
Value:$80
% of Portfolio:0.0% ($80/$3.0B)
WEST BANCORPORATION INC
Shares:4
Value:$80
% of Portfolio:0.0% ($80/$3.0B)
CITIZENS & NORTHERN CORP
Shares:4
Value:$80
% of Portfolio:0.0% ($80/$3.0B)